Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Explore value comparisons for travel points redemptions to make informed choices. Get the most out of your rewards.
22,567 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A major issuer boosted its quarterly dividend by 16%, even as shares retreat. This article breaks down what that sign...
Cumberland's 2025 earnings signal steady growth and improving margins, with a diversified product mix and a promising...
Bank of America issues two contrasting Buy ratings, backing Tesla’s autonomy roadmap and GM’s truck-led profitability...
Ripple gains a foothold in the core clearing network as NSCC lists a Ripple-linked entity. The move aligns with Rippl...
Regencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...
ACV Auctions delivered strong fourth-quarter numbers and a hopeful 2026 outlook, but shares plunged as investors weig...
Strategy reveals a fresh BTC buy totaling $1.28 billion, boosting its total stash to 738,731 BTC and signaling contin...
Fidelity’s zero-fee ETF has quietly tracked broad-market gains for years, delivering competitive returns with no expe...
Virginia’s starting question whether its data-center incentives are delivering broad value has moved into a high-stak...
Rocket Lab reports record backlog and margin gains, while Intuitive Machines pursues a transformative acquisition to ...
Campbell’s posts worst quarters as revenue and margins deteriorate across key segments. The company trims full-year t...